Magellan Health is exploring a sale of the company amid pressure from activist Starboard Value, Reuters reports, citing people familiar with the matter. Magellan is being advised by Goldman Sachs and is in the early stages of considering takeover interest, sources told Reuters. Shares of Magellan Health jumped 8%, or $5.11, to $70.13 following the report.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.